Method of treating thrombocytopenia using human BCDF in combination with IL-3
US5310550A · kind A · utility
1Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 9, 1992 |
| Grant date | May 10, 1994 |
| Priority date | — |
| Expiry date | Jan 9, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Thrombocytopenia is treated by administering a subject suffering from thrombocytopenia a composition containing human B cell differentiation activity in combination with IL-3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.